Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Boehringer Ingelheim
Fish and Richardson
UBS
Express Scripts

Generated: July 16, 2019

DrugPatentWatch Database Preview

Patent: 6,867,293

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,867,293
Title: Polynucleotide constructs having at least one transcriptional enhancer and encoding a modified rice EPSPS enzyme
Abstract:The invention is directed to polynucleotide constructs having at least one transcriptional enhancer operably liked to a rice EPSPS promoter and to a sequence encoding the rice EPSPS chloroplast transit peptide and rice EPSPS enzyme, the encoded enzyme having a modified region that confers herbicide resistance.
Inventor(s): Andrews; Christopher John (Bracknell, GB), Bachoo; Satvinder (Bracknell, GB), Hawkes; Timothy Robert (Bracknell, GB), Pickerill; Andrew Paul (Bracknell, GB), Warner; Simon Anthony James (Bracknell, GB)
Assignee: Syngenta Limited (Guilford, GB)
Application Number:10/012,070
Patent Claims:see list of patent claims

Details for Patent 6,867,293

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Try a Free Trial Syngenta Limited (Guilford, GB) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Try a Free Trial Syngenta Limited (Guilford, GB) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Try a Free Trial Syngenta Limited (Guilford, GB) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
AstraZeneca
Federal Trade Commission
Daiichi Sankyo
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.